Protein conjugate pneumococcal vaccines
- PMID: 11923145
- PMCID: PMC1122694
- DOI: 10.1136/bmj.324.7340.750
Protein conjugate pneumococcal vaccines
Erratum in
- BMJ 2002 Apr 27;324(7344):1002
References
-
- Black S, Shinefield H the Kaiser Permanente Vaccine Study Group. Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Pediatr Infect Dis J. 2000;9:187–195. - PubMed
-
- French N, Nakiyingi J, Carpenter M, Lugada E, Watera C, Moi K, et al. A double-blind randomised and placebo controlled trial of 23valent pneumococcal polysaccharide vaccine in HIV-1 infected Ugandan adults. Lancet. 2000;355:2106–2111. - PubMed
-
- King JC, Jr , Vink PE, Farley JJ, Parks M, Smilie M, Madore D, et al. Comparison of the safety and immunogenicity of a pneumococcal conjugate with a licensed polysaccharide vaccine in human immunodeficiency virus and non-human immunodeficiency virus-infected children. Pediatr Infect Dis J. 1996;15:192–196. - PubMed
-
- O'Brien KL, Swift AJ, Winkelstein JA, Santosham M, Stover B, Luddy R, et al. Safety and immunogenicity of heptavalent pneumococcal vaccine conjugated to CRM(197) among infants with sickle cell disease. Pneumococcal Conjugate Vaccine Study Group. Pediatrics. 2000;56:965–972. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical